picrotoxin has been researched along with Idiopathic Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bureau, SC; Fortin, T; Hayley, S; Link, GA; Ross, A; Sun, H; Wang, TT; Xing, V; Zhang, H | 1 |
| Chang, YM; Chen, CY; Chen, YL; Chou, JS; Lu, CS; Wang, HL; Weng, YH; Yeh, TH | 1 |
| Bevan, MD; Hallworth, NE | 1 |
| Hitti, FL; Kim, U; Lee, KH; Leiter, JC; Roberts, DW; Shalinsky, MH | 1 |
| Johnson, SW; Shen, KZ | 1 |
| Bernardi, G; Federici, M; Mercuri, NB | 1 |
6 other study(ies) available for picrotoxin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson's disease.
Topics: alpha-Synuclein; Amyloid; Cell Death; Cell Differentiation; Cell Line, Tumor; Electric Stimulation; Humans; Membrane Potentials; Models, Biological; Parkinson Disease; Picrotoxin; Potassium Chloride | 2020 |
(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.
Topics: Animals; Apomorphine; Cerebral Cortex; Corpus Striatum; Dopamine Agonists; Dopaminergic Neurons; GABA Antagonists; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Long-Term Potentiation; Mice; Mice, Transgenic; Motor Activity; Mutation; Parkinson Disease; Picrotoxin; Protein Serine-Threonine Kinases; Radionuclide Imaging; Serine; Substantia Nigra; Tyrosine 3-Monooxygenase | 2014 |
Globus pallidus neurons dynamically regulate the activity pattern of subthalamic nucleus neurons through the frequency-dependent activation of postsynaptic GABAA and GABAB receptors.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Evoked Potentials; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Globus Pallidus; Lysine; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Neurons; Parkinson Disease; Patch-Clamp Techniques; Picrotoxin; Pyridazines; Quinoxalines; Receptors, GABA-A; Receptors, GABA-B; Subthalamic Nucleus; Synapses; Tetrodotoxin | 2005 |
Abolition of spindle oscillations and 3-Hz absence seizurelike activity in the thalamus by using high-frequency stimulation: potential mechanism of action.
Topics: Action Potentials; Animals; Deep Brain Stimulation; Epilepsy; Essential Tremor; Female; Ferrets; GABA Antagonists; Male; Neurons; Neurotransmitter Agents; Parkinson Disease; Periodicity; Picrotoxin; Seizures; Synaptic Membranes; Thalamus | 2005 |
Subthalamic stimulation evokes complex EPSCs in the rat substantia nigra pars reticulata in vitro.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Agonists; GABA Antagonists; Glutamic Acid; In Vitro Techniques; Isonicotinic Acids; Neural Pathways; Neurons; Parkinson Disease; Patch-Clamp Techniques; Picrotoxin; Rats; Rats, Sprague-Dawley; Substantia Nigra; Subthalamic Nucleus; Synaptic Transmission; Time Factors | 2006 |
Inhibition of catechol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons.
Topics: Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Cells, Cultured; Dopamine; Dopamine Antagonists; Electrophysiology; Enzyme Inhibitors; GABA Antagonists; Glycine Agents; Levodopa; Male; Neurons; Nitrophenols; Organophosphorus Compounds; Parkinson Disease; Picrotoxin; Rats; Rats, Wistar; Strychnine; Substantia Nigra; Sulpiride; Synaptic Transmission; Tolcapone; Ventral Tegmental Area | 1999 |